Weitere Formate
Softcover - 9783642265228
213,99 €
Autorenfreundlich Bücher kaufen?!
Beschreibung
From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress. Here we give a brief overview of some key discoveries in the PI3K area and their impact, and include thoughts on the current state of the field, and where it could go from here
Volume 1
Volume 1
Details
| Verlag | Springer Berlin |
| Ersterscheinung | 01. Oktober 2010 |
| Maße | 23.5 cm x 15.5 cm |
| Gewicht | 705 Gramm |
| Format | Hardcover |
| ISBN-13 | 9783642136627 |
| Seiten | 310 |
Schlagwörter
Herstellerinformationen
Bekannt durch
